158 related articles for article (PubMed ID: 32657087)
1. Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era.
Cho SW; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi JH; Gwon HC; Lee SH; Choi SH
J Korean Med Sci; 2020 Jul; 35(27):e229. PubMed ID: 32657087
[TBL] [Abstract][Full Text] [Related]
2. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
3. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
4. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
5. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
Migliorini A; Valenti R; Parodi G; Vergara R; Buonamici P; Cerisano G; Carrabba N; Antoniucci D
JACC Cardiovasc Interv; 2016 May; 9(10):1001-7. PubMed ID: 27198680
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
7. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.
Yang CH; Hsieh MJ; Chen CC; Chang SH; Wang CY; Lee CH; Hsieh IC
Coron Artery Dis; 2012 Nov; 23(7):445-9. PubMed ID: 22968215
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
[TBL] [Abstract][Full Text] [Related]
9. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
[TBL] [Abstract][Full Text] [Related]
11. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
[TBL] [Abstract][Full Text] [Related]
12. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry).
Ueki Y; Miura T; Miyashita Y; Motoki H; Shimada K; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Hashizume N; Sekimura N; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
Am J Cardiol; 2016 Jan; 117(2):179-85. PubMed ID: 26684515
[TBL] [Abstract][Full Text] [Related]
14. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of SYNTAX score on 1 year outcome in patients underwent percutaneous coronary intervention].
Wang J; Guan CD; Yuan JS; Gao RL; Xu B; Qiao SB
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):267-273. PubMed ID: 29747321
[No Abstract] [Full Text] [Related]
16. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
[TBL] [Abstract][Full Text] [Related]
18. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
20. Utility of routine exercise treadmill testing early after percutaneous coronary intervention.
Babapulle MN; Diodati JG; Blankenship JC; Huynh T; Cugno S; Puri R; Nguyen PA; Eisenberg MJ
BMC Cardiovasc Disord; 2007 Mar; 7():12. PubMed ID: 17394661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
